Semler Scientific investors file class action lawsuit, deadline Oct. 28, 2025.
PorAinvest
domingo, 7 de septiembre de 2025, 8:32 am ET1 min de lectura
SMLR--
The lawsuit alleges that Semler Scientific did not disclose a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act. This failure to disclose led to investors suffering damages when the true details emerged [1]. The DOJ investigation was disclosed on February 28, 2025, resulting in a $4.03 drop in stock price, or a 9.4% decrease. On April 15, 2025, Semler announced a settlement with the DOJ for $29.75 million, leading to a further $3.40 drop in stock price, a 9.9% decrease [1].
Investors who purchased Semler securities during the Class Period have until October 28, 2025, to seek appointment as Lead Plaintiff in the lawsuit. This deadline is crucial as it allows investors to direct the litigation and potentially recover damages [1]. To participate or learn more about the class action, investors can contact Glancy Prongay & Murray LLP at 310-201-9150 or shareholders@glancylaw.com, or The Rosen Law Firm at 866-767-3653 or case@rosenlegal.com [1][2].
The Rosen Law Firm has a proven track record in securities class actions and has recovered hundreds of millions of dollars for investors. The firm has been ranked in the top 4 each year since 2013 and has achieved the largest ever securities class action settlement against a Chinese company [2].
Investors are encouraged to act promptly to protect their rights and potential compensation. For more information, visit https://rosenlegal.com/submit-form/?case_id=39889 or contact Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com.
References:
[1] https://www.morningstar.com/news/business-wire/20250905390183/deadline-alert-semler-scientific-inc-smlr-investors-who-lost-money-urged-to-contact-glancy-prongay-murray-llp-about-securities-fraud-lawsuit
[2] https://www.morningstar.com/news/pr-newswire/20250903dc64768/smlr-investors-have-opportunity-to-lead-semler-scientific-inc-securities-fraud-lawsuit-first-filed-by-the-rosen-law-firm
Semler Scientific, Inc. (NASDAQ: SMLR) has been sued for securities fraud by Rosen Law Firm on behalf of investors who bought the company's securities between March 10, 2021 and April 15, 2025. If you purchased Semler Scientific securities during this period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. To join the class action, visit rosenlegal.com or call Phillip Kim, Esq. at 866-767-3653.
Semler Scientific, Inc. (NASDAQ: SMLR) is facing a class action lawsuit alleging securities fraud and unlawful business practices. The lawsuit, filed by The Rosen Law Firm on behalf of investors who purchased Semler securities between March 10, 2021, and April 15, 2025, claims that the company made materially false and misleading statements and failed to disclose significant adverse facts about its business and operations.The lawsuit alleges that Semler Scientific did not disclose a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act. This failure to disclose led to investors suffering damages when the true details emerged [1]. The DOJ investigation was disclosed on February 28, 2025, resulting in a $4.03 drop in stock price, or a 9.4% decrease. On April 15, 2025, Semler announced a settlement with the DOJ for $29.75 million, leading to a further $3.40 drop in stock price, a 9.9% decrease [1].
Investors who purchased Semler securities during the Class Period have until October 28, 2025, to seek appointment as Lead Plaintiff in the lawsuit. This deadline is crucial as it allows investors to direct the litigation and potentially recover damages [1]. To participate or learn more about the class action, investors can contact Glancy Prongay & Murray LLP at 310-201-9150 or shareholders@glancylaw.com, or The Rosen Law Firm at 866-767-3653 or case@rosenlegal.com [1][2].
The Rosen Law Firm has a proven track record in securities class actions and has recovered hundreds of millions of dollars for investors. The firm has been ranked in the top 4 each year since 2013 and has achieved the largest ever securities class action settlement against a Chinese company [2].
Investors are encouraged to act promptly to protect their rights and potential compensation. For more information, visit https://rosenlegal.com/submit-form/?case_id=39889 or contact Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com.
References:
[1] https://www.morningstar.com/news/business-wire/20250905390183/deadline-alert-semler-scientific-inc-smlr-investors-who-lost-money-urged-to-contact-glancy-prongay-murray-llp-about-securities-fraud-lawsuit
[2] https://www.morningstar.com/news/pr-newswire/20250903dc64768/smlr-investors-have-opportunity-to-lead-semler-scientific-inc-securities-fraud-lawsuit-first-filed-by-the-rosen-law-firm
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios